Type 2 diabetes is a disease of metabolic dysfunction characterised by insulin resistance in peripheral tissues and eventual failure of pancreatic beta cell insulin secretion. It is largely preventable and partially reversible in its early stages through dietary and lifestyle change. The Mediterranean diet addresses the metabolic pathways underlying insulin resistance through multiple components and has an extensive evidence base for both diabetes prevention and management in established disease.

Prevention Evidence

A 2014 meta-analysis of 17 prospective cohort studies following over 160,000 participants found that higher Mediterranean diet adherence was associated with a 23 per cent reduction in incident type 2 diabetes. The PREDIMED trial, which enrolled participants at high cardiovascular risk with consequently high rates of metabolic syndrome, found that Mediterranean diet reduced the transition from impaired glucose metabolism to overt type 2 diabetes by approximately 52 per cent compared to the low-fat control diet. These are among the largest dietary effect sizes reported for a specific chronic disease outcome.

Mechanisms: Glycaemic Response

The Mediterranean diet produces lower postprandial glycaemic responses than Western-pattern diets through several mechanisms. The high fibre content of legumes and vegetables slows carbohydrate absorption and reduces postprandial glucose peaks. The polyphenols in olive oil, red wine, and plant foods inhibit intestinal alpha-glucosidase, the enzyme that cleaves complex carbohydrates into absorbable glucose, reducing postprandial glycaemia. The high monounsaturated fat content improves hepatic insulin sensitivity. And the overall low glycaemic load of the Mediterranean diet pattern, without the refined carbohydrates and sugars that drive glycaemic excursions, reduces the cumulative insulin demand that eventually overwhelms beta cell capacity.

Management in Established Diabetes

For people with established type 2 diabetes, randomised trials comparing Mediterranean diet to standard low-fat dietary advice find that Mediterranean diet produces greater reductions in HbA1c, the long-term glycaemic control marker, and reduces the need for antidiabetic medication. A 2014 systematic review by Esposito and colleagues found that Mediterranean diet produced mean HbA1c reductions of 0.47 per cent compared to control diets in type 2 diabetes, an effect comparable to the addition of a second oral hypoglycaemic agent. This is a clinically meaningful reduction achievable through dietary change alone.

Practical Priorities for Metabolic Health

For metabolic health specifically, the most evidence-supported Mediterranean diet components are: replacing refined grains with whole grains and legumes; using extra-virgin olive oil as the primary fat; including oily fish multiple times per week for omega-3s; eating vegetables at every meal, with emphasis on non-starchy varieties; and eliminating sugary drinks and ultra-processed foods. Adding cinnamon, which has documented effects on postprandial glucose regulation, and vinegar with meals, which similarly attenuates glycaemic response, provides additional metabolic benefit within the overall dietary pattern.

Share this article

LinkedInFacebookWhatsApp